Tempus Unveils Tempus O, a Platform to Structure and Annotate Clinical Data at Scale
07 déc. 2017 12h22 HE
|
Tempus
CHICAGO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data...
Tempus Announces Latest Immunotherapy Project
15 nov. 2017 10h15 HE
|
Tempus
CHICAGO, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data,...
Tempus and Sanford Health Collaborate on Personalized Medicine Initiative
01 nov. 2017 10h15 HE
|
Tempus
CHICAGO, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Tempus, a rapidly-growing technology company focused on collecting and integrating molecular and clinical data and Sanford Health, one of the largest...
Tempus Unveils Tempus xT, 595 Gene Panel Aimed at Empowering Data-Driven Cancer Care
19 oct. 2017 10h30 HE
|
Tempus
CHICAGO, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Tempus today announced the launch of its new comprehensive genomic sequencing panel, Tempus xT, which analyzes 595 genes relevant to the diagnosis,...
Tempus and the OHSU Knight Cancer Institute Collaborating on Personalized Medicine Data Initiative
28 sept. 2017 10h00 HE
|
Tempus
CHICAGO, Sept. 28, 2017 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data,...
Tempus Announces $130M Raised
25 sept. 2017 09h00 HE
|
Tempus
CHICAGO, Sept. 25, 2017 (GLOBE NEWSWIRE) -- Tempus announced today that it closed a $70M, Series C, round of venture funding co-led by New Enterprise Associates (NEA) and Revolution Growth. This...
Tempus and Cleveland Clinic Collaborate on Personalized Medicine Initiative
14 sept. 2017 10h30 HE
|
Tempus
CHICAGO, Sept. 14, 2017 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data,...
Tempus and University of California Davis Comprehensive Cancer Center Announce Personalized Medicine Partnership for Cancer Patients
31 août 2017 10h00 HE
|
Tempus
CHICAGO, Aug. 31, 2017 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data...
Tempus Selected as Sequencing and Analytics Provider by the Prostate Cancer Clinical Trials Consortium for Phase II Clinical Trial
17 août 2017 09h00 HE
|
Tempus
CHICAGO, Aug. 17, 2017 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data...
Tempus Selected by University of Virginia As Partner for Large Granular Lymphocyte Leukemia Research Project
03 août 2017 10h00 HE
|
Tempus
CHICAGO, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and integrating molecular and clinical data, and the...